References
- Braquet P, Vargaftig B B. Pharmacology of platelet activating factor. Transplant Proc 1986; 28: 10–19
- Wallace J L, Steel G, Whiffle B, Lagente V, Vargaftig B B. Evidence for platelet‐activating factor as a mediator of endotoxin‐induced gastrointestinal damage in the rat. Gastroenterology 1983; 93: 765–773
- Rosam A C, Wallace J L, Whittle B J R. Ulcerogenic actions of platelet‐activating factor on the stomach. Nature 1986; 319: 54–56
- Boughton‐Smith N K, Whittle B J R. Formation of the pro‐inflammatory mediator, PAF‐acether in different models of colitis. Gastroenterology 1988; 94: A45
- Eliakim R, Karmeli F, Razin E, Rachmilewitz D. Role of platelet‐activating factor in ulcerative colitis. Gastroenterology 1988; 95: 1167–1172
- Kald B, Olaison G, Sjödahl R, Tagesson C. Novel aspect of Crohn's disease: increased content of platelet‐activating factor in ileal and colonic mucosa. Digestion 1990; 46: 199–204
- Camussi G, Aglietta M, Coda R, Bussolino F, Piacibello W, Tetta C. Release of platelet‐activating factor (PAF) and histamine. I. I. The cellular origin of human PAF: monocytes, polymorphonuclear neutrophils and basophils. Immunology 1981; 42: 191–199
- Chao W, Siafaka–Kapadai A, Olson M S, Hanahan D J. Biosynthesis of platelet‐activating factor by cultured rat Kuppfer cells stimulated with calcium ionophore A23187. Biochem J 1989; 257: 823–829
- Camussi G, Aglietta M, Malavasi F, et al. The release of platelet‐activating factor from human endothelial cells in culture. J Immunol 1983; 131: 1812–1807
- Michel L, Denizot Y, Thomas Y, et al. Biosynthesis of PAF‐acether by human skin fibroblasts in vitro. J Immunol 1988; 141: 948–953
- Gustafson C, Tagesson C. Phospholipase activation and arachidonic acid release in cultured intestinal epithelial cells (INT 407). Scand J Gastroenterol 1989; 24: 475–484
- Gustafson C, Tagesson C. Phospholipase C from Clostridium perfringens stimulates phospholipase A2‐mediated arachidonic acid release in cultured intestinal epithelial cells (INT 407). Scand J Gastroenterol 1990; 25: 363–371
- Henle G, Deinhart F. The establishment of strains of human cells in tissue culture. Immunology 1957; 79: 54–59
- Yada T, Okada Y. Electrical activity of an intestinal epithelial cell line: hyperpolarizing responses to intestinal secretagogues. J Membrane Biol 1984; 77: 33–44
- Bligh E G, Dyer W J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37: 911–917
- Baldo B A, Smal M A, McCaskill A. A specific and sensitive radioimmunoassay for platelet‐activating factor (PAF). Du Pont Biotech Update 1990; 4(no. 4)
- Blank M L, Lee T, Fitzgerald V, Snyder F. A specific acetylhydrolase for l‐alkyl‐2‐acetyl‐sn‐gly cero‐3‐phosphocholine (a hypotensive and platelet‐activating factor). J Biol Chem 1981; 256: 175–178
- Nakamuro T, Morita Y, Kuriyama M, Ishihara K, Ito K, Miyamoto T. Platelet‐activating factor in late‐asmatic response. Int Arch Allergy Appl Immunol 1987; 82: 57–61
- Snyder F. Biochemistry of platelet‐activating factor. A unique class of biologically active phospholipids. Proc Soc Exp Biol Med 1989; 190: 125–135
- Waite M. The phospholipases. Handbook of lipid research, D J Hanahan. Plenum Press, New York 1987; Vol 5
- Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumor promotion. Nature 1984; 308: 693–698
- Touqui L, Rothhut B, Shaw A M, Fradin A, Vargaftig B B, Russo‐Marie F. Platelet activation—a role for a 40K antiphospholipase A2 protein indistinguishable from lipocortin. Nature 1986; 321: 177–180
- Billah M M, Siegel M I. Calmodulin antagonists inhibit formation of platelet‐activating factor in stimulated human neutrophils. Biochem Biophys Res Comm 1984; 118: 629–653
- Verheij H M, Slotboom A J, de Haas G H. Structure and function of phospholipase A2. Rev Physiol Biochem Pharmacol 1981; 91: 91–203
- Cabot M C, Blank M L, Welsh C J, Horan M J, Cress E A, Snyder F. Metabolism of 1‐alkyl‐2‐acetyl‐sn glycero‐3‐phosphocholine by cell cultures. Life Sci 1982; 31: 2891–2898
- Pieroni G, Hanahan D J. Metabolic behavior of acetyl glyceryl ether phosphorylcholine on interaction with rabbit platelets. Arch Biochem Biophys 1983; 224: 485–493
- Gustafson C, Franzén L, Tagesson C. Phospholipase activation and arachidonic acid release in isolated intestinal epithelial cells. Scand J Gastroenterol 1988; 23: 413–421
- Gustafson C, Sjödahl R, Tagesson C. Phospholipase activation and arachidonic acid release in intestinal epithelial cells from patients with Crohn's disease. Scand J Gastroenterol 1990; 25: 1151–1160
- Olhagen B, Månsson I. Intestinal Clostridium perfringens in rheumatoid arthritis and other collagen diseases. Acta Med Scand 1968; 184: 395–402
- Månsson I, Norberg R, Olhagen B, Björklund N ‐E. Arthritis in pigs induced by dietary factors. Microbiologic, clinical and histologic studies. Clin Exp Immunol 1971; 9: 677–693
- Olhagen B. Intestinal Clostridium perfringens in arthritis and allied conditions. Infection and immunology in the rheumatic disease, D C Dumonde. Blackwell Scientific Publications, Oxford 1976; 141–145